CompletedNot Applicable

Optimal Metabolic Health Through Continuous Glucose Monitoring

United States66 participantsStarted 2021-05-10

Plain-language summary

The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against chronic and infectious diseases.

Who can participate

Age range18 Years – 69 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ages 18-69 years of age * Desire to improve metabolic health through nutritional, fitness, cognitive, and behavioral therapies. * Voluntarily participate in either a live or virtual 12-week, multidisciplinary wellness program created and led by Allison Hull, DO. * Body Mass Index (BMI) \> 20 kg/m2 * Fasting Blood Glucose (FBG) of 85-125 mg/dl * HbA1c of 5.0-6.4 % Exclusion Criteria: * Type 1 or 2 Diabetes. * Chronic Kidney Disease * End Stage Liver Disease * Use of any weight loss medications currently or in the past 3 months. * Disordered Eating - anorexia or bulimia nervosa. * Pregnant or Breastfeeding females.

What they're measuring

Glucose stability from baseline to 12 weeks as measured by Continuous Glucose Monitoring (CGM)

Timeframe: 12 weeks

Glucose stability from baseline to 12 weeks as measured by hemoglobin A1c (HbA1c)

Timeframe: 12 weeks

Trial details

NCT IDNCT04920058

SponsorUniversity of South Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-18

View on ClinicalTrials.gov More Metabolic Syndrome trials